HOME >> BIOLOGY >> NEWS
FSU engineering professor growing bone in a lab

TALLAHASSEE, Fla.-- As the nation ages, an estimated 44 million Americans, including at least half of those ages 50 and older, are at risk for osteoporosis, making their bones fragile and vulnerable to serious fractures.

Now, a Florida State University engineering professor is looking to develop new technologies that could replace bone mass lost to the disease, as well as treat traumatic bone injuries such as those suffered in automobile accidents or combat. Teng Ma, an associate professor of chemical and biomedical engineering at the Florida A&M University-FSU College of Engineering, and two colleagues have received an $824,000, four-year grant from the U.S. Department of Defense to research ways of generating bone cells in a laboratory that then could be transplanted into human patients.

"The Department of Defense's main interest in this research is its potential for developing new treatments and therapies for military personnel who have suffered bone loss due to diseases or traumatic injuries," Ma said. "However, many other types of patients who suffer from bone diseases could benefit from this research as well."

Ma pointed to recent students showing that tissue-engineered bone grafts are effective for correcting bone defects resulting from osteoporosis and other bone-related diseases. One out of every two women and one in four men over the age of 50 eventually will suffer an osteoporosis-related fracture, and many more are at risk. Such fractures typically occur in the hip, spine and wrist.

"Currently, there are two sources of bone that can be used for performing corrective grafts -- the patient's own body and human cadavers," Ma said. "Both of these have severe limitations. There is a limited supply, obviously, of bone tissue that can be taken from one part of the patient's body to be grafted onto another. And with cadaveric bone" -- bone taken from human cadavers -- "immune response and the possibility of viral infect
'"/>

Contact: Teng Ma
teng@eng.fsu.edu
850-410-6558
Florida State University
21-May-2007


Page: 1 2

Related biology news :

1. New UD tissue-engineering research focuses on vocal cords
2. Small, self-controlled planes combine plant pathology and engineering
3. UC engineering researchers uncover factors that control ion motion in solid electrolytes
4. UD scientist wins NSF career award for tissue engineering research
5. New success in engineering plant oils
6. Bioengineering efficient antibiotic biosynthesis in E. coli
7. More women students choose engineering -- but not as a career
8. Bioengineer wins $500,000 engineering prize
9. Researchers to present advances in energy, health, technology at chemical engineering conference
10. Research Council feted NJIT chemical engineering professor
11. Genome archaeology illuminates the genetic engineering debate

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: FSU engineering professor growing bone lab

(Date:5/21/2013)... 21, 2013 Royal Philips Electronics (NYSE: PHG, ... first portable ultrasound with Philips, industry leading Live 3D ... CX50 xMATRIX with available Live 3D TEE and ICE ... at the EuroPCR, official meeting for the European Association ... Since its launch in 2012, Philips CX50 xMATRIX has ...
(Date:5/21/2013)... the way genes function without changing the underlying ... blood of pregnant women during any trimester, potentially ... the weeks after giving birth, and an opportunity ... findings of the small study involving 52 pregnant ... Molecular Psychiatry . , "Postpartum depression can be ...
(Date:5/20/2013)... also commonly resistant to antimicrobial substances made by ... mBio , the online open-access journal of ... and host antimicrobials LL-37 and lysozyme, which help ... that patients with life-threatening multi-drug resistant infections are ... is a last-line drug for treating several kinds ...
Breaking Biology News(10 mins):Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3
(Date:5/21/2013)... Raleigh, NC (PRWEB) May 21, 2013 ... and financial services company for clinical trials, announced ... Aggregate Spend Solutions, LLC. Clinverse’s ClinPay® FLS ... automated investigator payment process. SpendMD ™, ... only complete solution for tracking and reporting transfer ...
(Date:5/21/2013)... 21, 2013 Smarter Security, Inc., provider ... today announced that Genzyme, a Sanofi company and leading ... Detective® CL for a multi-use facility in the United ... other Genzyme buildings, this latest order underscores the satisfaction ... tailgate detection device improving doorway access control. ...
(Date:5/21/2013)... ALBANY, New York , May 21, 2013 /PRNewswire/ ... published by Transparency Market Research ( http://www.transparencymarketresearch.com ) "Biochip ... Science Research, IVD Tests) - U.S. Industry Analysis, Size, Share, ... USD 2.4 billion in 2011 and is expected to ... 2018, to reach an estimated value of USD 4.7 ...
(Date:5/21/2013)... May 21, 2013 As the ... strong push within the industry to deliver better ... Organizations and pharma companies often means turning big ... Microtablets, developed in collaboration with Sensidose AB and ... can bring products to market sooner. The partnership ...
Breaking Biology Technology:Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2
Cached News: